{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T22:48:25Z","timestamp":1778107705485,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:00:00Z","timestamp":1443484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Institutional funds"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s10549-015-3573-2","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T07:49:35Z","timestamp":1443512975000},"page":"359-367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors"],"prefix":"10.1007","volume":"154","author":[{"given":"Adrienne G.","family":"Waks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara M.","family":"Tolaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Galar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Arnaout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie B.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco M.","family":"Marty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric P.","family":"Winer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah P.","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey R.","family":"Baden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,29]]},"reference":[{"key":"3573_CR1","unstructured":"Seer stat fact sheets: Breast cancer. seer.cancer.gov\/statfactshtml\/breast.html"},{"issue":"12","key":"3573_CR2","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/cncr.28607","volume":"120","author":"R Jagsi","year":"2014","unstructured":"Jagsi R, Hawley ST, Abrahamse P, Li Y, Janz NK, Griggs JJ, Bradley C, Graff JJ, Hamilton A, Katz SJ (2014) Impact of adjuvant chemotherapy on long-term employment of survivors of early-stage breast cancer. Cancer 120(12):1854\u20131862","journal-title":"Cancer"},{"issue":"5","key":"3573_CR3","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bjc.6602412","volume":"92","author":"LJ Worth","year":"2005","unstructured":"Worth LJ, Dooley MJ, Seymour JF, Mileshkin L, Slavin MA, Thursky KA (2005) An analysis of the utilisation of chemoprophylaxis against pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital. Br J Cancer 92(5):867\u2013872","journal-title":"Br J Cancer"},{"issue":"3","key":"3573_CR4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199001183220304","volume":"322","author":"J Phair","year":"1990","unstructured":"Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A (1990) The risk of pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter aids cohort study group. N Engl J Med 322(3):161\u2013165","journal-title":"N Engl J Med"},{"issue":"1","key":"3573_CR5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","volume":"71","author":"SH Yale","year":"1996","unstructured":"Yale SH, Limper AH (1996) Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 71(1):5\u201313","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"3573_CR6","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jama.1992.03480060078034","volume":"267","author":"KA Sepkowitz","year":"1992","unstructured":"Sepkowitz KA, Brown AE, Telzak EE, Gottlieb S, Armstrong D (1992) Pneumocystis carinii pneumonia among patients without aids at a cancer hospital. JAMA 267(6):832\u2013837","journal-title":"JAMA"},{"issue":"2","key":"3573_CR7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1086\/514542","volume":"25","author":"MH Kulke","year":"1997","unstructured":"Kulke MH, Vance EA (1997) Pneumocystis carinii pneumonia in patients receiving chemotherapy for breast cancer. Clin Infect Dis 25(2):215\u2013218","journal-title":"Clin Infect Dis"},{"issue":"9","key":"3573_CR8","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1002\/1097-0142(19910501)67:9<2407::AID-CNCR2820670932>3.0.CO;2-X","volume":"67","author":"MW Brunvand","year":"1991","unstructured":"Brunvand MW, Collins C, Livingston RB, Raghu G (1991) Pneumocystis carinii pneumonia associated with profound lymphopenia and abnormal t-lymphocyte subset ratios during treatment for early-stage breast carcinoma. Cancer 67(9):2407\u20132409","journal-title":"Cancer"},{"issue":"10","key":"3573_CR9","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1086\/379071","volume":"37","author":"RC Larocque","year":"2003","unstructured":"Larocque RC, Katz JT, Perruzzi P, Baden LR (2003) The utility of sputum induction for diagnosis of pneumocystis pneumonia in immunocompromised patients without human immunodeficiency virus. Clin Infect Dis 37(10):1380\u20131383","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3573_CR10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/504811","volume":"43","author":"SI Martin","year":"2006","unstructured":"Martin SI, Marty FM, Fiumara K, Treon SP, Gribben JG, Baden LR (2006) Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. Clin Infect Dis 43(1):16\u201324","journal-title":"Clin Infect Dis"},{"issue":"4","key":"3573_CR11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/07357900701206380","volume":"25","author":"AB Schwarzberg","year":"2007","unstructured":"Schwarzberg AB, Stover EH, Sengupta T, Michelini A, Vincitore M, Baden LR, Kulke MH (2007) Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. Cancer Investig 25(4):249\u2013255","journal-title":"Cancer Investig"},{"issue":"8","key":"3573_CR12","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1200\/JCO.2003.09.081","volume":"21","author":"ML Citron","year":"2003","unstructured":"Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ, Davidson NE, Martino S, Livingston R, Ingle JN, Perez EA, Carpenter J, Hurd D, Holland JF, Smith BL, Sartor CI, Leung EH, Abrams J, Schilsky RL, Muss HB, Norton L (2003) Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of intergroup trial c9741\/cancer and leukemia group b trial 9741. J Clin Oncol 21(8):1431\u20131439","journal-title":"J Clin Oncol"},{"issue":"33","key":"3573_CR13","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1200\/JCO.2006.08.1083","volume":"24","author":"SM Tolaney","year":"2006","unstructured":"Tolaney SM, Partridge AH, Sheib RG, Burstein HJ, Winer EP (2006) Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer. J Clin Oncol 24(33):5330\u20135331","journal-title":"J Clin Oncol"},{"issue":"4","key":"3573_CR14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1378\/chest.06-1467","volume":"131","author":"S Tasaka","year":"2007","unstructured":"Tasaka S, Hasegawa N, Kobayashi S, Yamada W, Nishimura T, Takeuchi T, Ishizaka A (2007) Serum indicators for the diagnosis of pneumocystis pneumonia. Chest 131(4):1173\u20131180","journal-title":"Chest"},{"issue":"1","key":"3573_CR15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.7326\/0003-4819-147-1-200707030-00018","volume":"147","author":"FM Marty","year":"2007","unstructured":"Marty FM, Koo S, Bryar J, Baden LR (2007) (1\u21923)beta-d-glucan assay positivity in patients with pneumocystis (carinii) jiroveci pneumonia. Ann Intern Med 147(1):70\u201372","journal-title":"Ann Intern Med"},{"issue":"11","key":"3573_CR16","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/647942","volume":"49","author":"S Koo","year":"2009","unstructured":"Koo S, Bryar JM, Page JH, Baden LR, Marty FM (2009) Diagnostic performance of the (1\u21923)-beta-d-glucan assay for invasive fungal disease. Clin Infect Dis 49(11):1650\u20131659","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3573_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1469-0691.2011.03760.x","volume":"19","author":"DE Karageorgopoulos","year":"2013","unstructured":"Karageorgopoulos DE, Qu JM, Korbila IP, Zhu YG, Vasileiou VA, Falagas ME (2013) Accuracy of beta-d-glucan for the diagnosis of pneumocystis jirovecii pneumonia: a meta-analysis. Clinl Microbiol Infect 19(1):39\u201349","journal-title":"Clinl Microbiol Infect"},{"issue":"4","key":"3573_CR18","doi-asserted-by":"crossref","first-page":"379 e371","DOI":"10.1016\/j.cmi.2014.11.025","volume":"21","author":"F Esteves","year":"2015","unstructured":"Esteves F, Cale SS, Badura R, De Boer MG, Maltez F, Calderon EJ, Van Der Reijden TJ, Marquez-Martin E, Antunes F, Matos O (2015) Diagnosis of pneumocystis pneumonia: evaluation of four serologic biomarkers. Clin Microbiol Infect 21(4):379 e371\u2013379 e310","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"3573_CR19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jiac.2014.07.001","volume":"20","author":"S Tasaka","year":"2014","unstructured":"Tasaka S, Kobayashi S, Yagi K, Asami T, Namkoong H, Yamasawa W, Ishii M, Hasegawa N, Betsuyaku T (2014) Serum (1\u21923) beta-d-glucan assay for discrimination between pneumocystis jirovecii pneumonia and colonization. J Infect Chemother 20(11):678\u2013681","journal-title":"J Infect Chemother"},{"issue":"6","key":"3573_CR20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/QAD.0b013e32835cb646","volume":"27","author":"BR Wood","year":"2013","unstructured":"Wood BR, Komarow L, Zolopa AR, Finkelman MA, Powderly WG, Sax PE (2013) Test performance of blood beta-glucan for pneumocystis jirovecii pneumonia in patients with aids and respiratory symptoms. Aids 27(6):967\u2013972","journal-title":"Aids"},{"issue":"1\u20132","key":"3573_CR21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11046-012-9579-y","volume":"175","author":"ES Theel","year":"2013","unstructured":"Theel ES, Jespersen DJ, Iqbal S, Bestrom JE, Rollins LO, Misner LJ, Markley BJ, Mandrekar J, Baddour LM, Limper AH, Wengenack NL, Binnicker MJ (2013) Detection of (1, 3)-beta-d-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts. Mycopathologia 175(1\u20132):33\u201341","journal-title":"Mycopathologia"},{"issue":"2","key":"3573_CR22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cid\/cir335","volume":"53","author":"PE Sax","year":"2011","unstructured":"Sax PE, Komarow L, Finkelman MA, Grant PM, Andersen J, Scully E, Powderly WG, Zolopa AR, Team ACTGSA (2011) Blood (1\u21923)-beta-d-glucan as a diagnostic test for hiv-related pneumocystis jirovecii pneumonia. Clin Infect Dis 53(2):197\u2013202","journal-title":"Clin Infect Dis"},{"key":"3573_CR23","first-page":"1594","volume-title":"Goodman and gilman\u2019s the pharmacological basis of therapeutics","year":"2006","unstructured":"Brunton LL (ed) (2006) Goodman and gilman\u2019s the pharmacological basis of therapeutics, vol 11. The McGraw-Hill Companies, Inc, New York, p 1594"},{"issue":"4","key":"3573_CR24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3816\/CBC.2008.n.041","volume":"8","author":"SM Tolaney","year":"2008","unstructured":"Tolaney SM, Najita J, Winer EP, Burstein HJ (2008) Lymphopenia associated with adjuvant anthracycline\/taxane regimens. Clin Breast Cancer 8(4):352\u2013356","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"3573_CR25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3324\/haematol.10564","volume":"92","author":"A Kolstad","year":"2007","unstructured":"Kolstad A, Holte H, Fossa A, Lauritzsen GF, Gaustad P, Torfoss D (2007) Pneumocystis jirovecii pneumonia in b-cell lymphoma patients treated with the rituximab-choep-14 regimen. Haematologica 92(1):139\u2013140","journal-title":"Haematologica"},{"issue":"2","key":"3573_CR26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000334113","volume":"127","author":"E Hardak","year":"2012","unstructured":"Hardak E, Oren I, Dann EJ, Yigla M, Faibish T, Rowe JM, Avivi I (2012) The increased risk for pneumocystis pneumonia in patients receiving rituximab-chop-14 can be prevented by the administration of trimethoprim\/sulfamethoxazole: a single-center experience. Acta Haematol 127(2):110\u2013114","journal-title":"Acta Haematol"},{"issue":"2","key":"3573_CR27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00277-012-1592-1","volume":"92","author":"T Kim","year":"2013","unstructured":"Kim T, Choi SH, Kim SH, Jeong JY, Woo JH, Kim YS, Sung H, Kim MN, Yoon DH, Suh C, Lee SO (2013) Point prevalence of pneumocystis pneumonia in patients with non-hodgkin lymphoma according to the number of cycles of r-chop chemotherapy. Ann Hematol 92(2):231\u2013238","journal-title":"Ann Hematol"},{"issue":"3","key":"3573_CR28","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1378\/chest.118.3.712","volume":"118","author":"NG Mansharamani","year":"2000","unstructured":"Mansharamani NG, Balachandran D, Vernovsky I, Garland R, Koziel H (2000) Peripheral blood cd4+t-lymphocyte counts during pneumocystis carinii pneumonia in immunocompromised patients without hiv infection. Chest 118(3):712\u2013720","journal-title":"Chest"},{"issue":"6\u20137","key":"3573_CR29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/00365540601150497","volume":"39","author":"UM Overgaard","year":"2007","unstructured":"Overgaard UM, Helweg-Larsen J (2007) Pneumocystis jiroveci pneumonia (pcp) in hiv-1-negative patients: a retrospective study 2002\u20132004. Scand J Infect Dis 39(6\u20137):589\u2013595","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"3573_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1200\/JCO.2013.51.4547","volume":"32","author":"F Roila","year":"2014","unstructured":"Roila F, Ruggeri B, Ballatori E, Del Favero A, Tonato M (2014) Aprepitant versus dexamethasone for preventing chemotherapy-induced delayed emesis in patients with breast cancer: a randomized double-blind study. J Clin Oncol 32(2):101\u2013106","journal-title":"J Clin Oncol"},{"issue":"31","key":"3573_CR31","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","volume":"29","author":"E Basch","year":"2011","unstructured":"Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B, Morrow G, Rao KV, Schwartz RN, Lyman GH, American Society of Clinical O (2011) Antiemetics: american society of clinical oncology clinical practice guideline update. J Clin Oncol 29(31):4189\u20134198","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3573-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-015-3573-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3573-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:43:16Z","timestamp":1559234596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-015-3573-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,29]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["3573"],"URL":"https:\/\/doi.org\/10.1007\/s10549-015-3573-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,29]]}}}